R-EPOCH is a cancer treatment that combines six chemotherapy drugs. Combination therapies often work better than single drugs because they each fight cancer cells in different ways. R-EPOCH is ...

Think this is nice? It’s a version of the weekly Under 30 newsletter and would be even better in your inbox. Palo-Alto based Fusion Fund team In 2015, Lu Zhang launched her own venture capital ...

Epoch Biodesign Research and Development Laboratory. Credits: Epoch Biodesign. Disruptive British start-up Epoch Biodesign has announced the closing of a Series A financing round of 18.3 million ...

Epoch BioDesign has raised $18.3 million in Series A funding. The investment will support the company’s use of enzymes in recycling plastics. Traditional mechanical recycling struggles with mixed ...

Epoch Biodesign, a UK-based innovator in biorecycling, has successfully raised $18.3 million in its Series A funding round, with Goodwin Procter advising the startup. The funding will help the company ...

and chemical firms Epoch Biodesign has announced it has raised $18.3m to accelerate its efforts to harness plastic-eating enzymes to make recycled plastics cheaper and higher performing than ...

TechCrunch recently profiled Epoch Biodesign, a company that's been working to take founder Jacob Nathan's highschool project worldwide. The startup has just received $18.3 million in Series A ...